Digipharm — a decentrialized blockchain-based which is going to transform how healthcare systems work
The market for healthcare with the application of technology is in demand nowadays. According to Market Research Reports, Marketing Research Company, Business Research by MarketsandMarkets, the IoT healthcare market is projected to grow from USD 41.22 billion in 2017 to USD 158.07 billion by 2022. Major growth drivers of the IoT healthcare market are evolution of AI technology, rise in investments for the implementation of IoT healthcare solutions, and the increasing penetration of connected devices in healthcare. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.
With that trend, X-as-a-service solutions to become the powerful tool to achieve competitive advantage in healthcare
X-as-a-service models will gain more prominence opening up new revenue streams for future sustainability for healthcare industry. In addition, estimate service-based models are estimated to contribute 2–3% revenue for leading drug and sevices companies in next 2–3 years’ time. Entailing this transition towards service focused PaaS and DaaS business models, funding, spend, and revenue will continue the shift from CapEx to OpEx as relates to the IT enablement of desired business outcomes. Turning data into action will be the new sources of innovation and service-oriented future revenue streams where differentiation via intelligent solutions and services outcome-based health benefits will be critical to demonstrate value to end users.
More advancedly, Digipharm applies the innovation of blockchain technology which will be a disruptive project in the future.
The current problems
Obsolete flaws and infrastructural obstacles of the worldwide healthcare structures bring about huge inefficiency, wastage and sub-surest health effects for the most crucial stakeholder who is the patient.
Innovative pricing models offer viable solutions to the aforementioned problems. Unfortunately, most healthcare providers or payers around the world lack the applicable infrastructure to track and enforce results based ob pricing agreements, and so are shy in adopting revolutionary pricing contracts and rules. In healthcare nowadays, there is a lack of incentive for health systems and providers to awareness on at the same time beneficial collaboration and the maximization of patient results. Even though it is widely agreed that the transition to value primarily based pricing is important, development in doing so has been slow.
In addition to the barriers in enforcing final results based on pricing, patient data is fragmented. Also, the shortage of without difficulty available and comprehensive real world evidencestatistics currently prevents stakeholders in healthcare to assess the real time performance and price provided via therapy in real life clinical exercise as a part of a value based healthcare delivery device.
Digipharm- the solution
Digipharm targets at utilizing the innovative blockchain technology to conquer obstacles which allow patients to get access to revolutionary pricing model, decrease expenses for all stakeholders, and bypass infrastructural barriers to drive more value (value-based), incentivise innovation and expedite the transformation to customized healthcare. Using the technology of blockchain, Digipharm combines healthcare industry expertise and decentralization, transforming how the healthcare systems work.
Digipharm would like to become the pioneer of value-based healthcare delivery, revolutionary evidence generation and patient empowerment throughout the healthcare industry applying the technology of blockchain.
A review to answer your question: “Should I invest in Digipharm?”
- A strong partnership between Digipharm and Swisscom Blockchain
Swisscom Blockchain and Digipharm are working together to develop blockchain-based platforms for healthcare. Their shared aim is to bring about fair pricing and personalised therapy.Swisscom is a giant in Switzerland, being the leading telecommunications company, and one of the top IT companies as well. With over $12.2 in revenue in 2017, over 66% of the population use the Swisscom network, and 51`% of the company is owned by the Swiss Confederation.
Swisscom announced their exploration into blockchain technology September 2017, and since then has been approached by hundreds of blockchain projects. Swisscom has been highly selective in whom they choose to associate themselves with, which is another testament for Digipharm.
The partnership intends to pave the way for bringing “fair pricing to healthcare and push the transition towards personalised therapy”, explains Ahmed Abdulla, founder and CEO of Digipharm, in the press release. Swisscom is confident that “their platforms and vision are well placed to lead the advance of real world uptake for blockchain technology in healthcare,” as Sven Möller, Head of ICO at Swisscom Blockchain explained. A minimum viable product is currently in development, with the launch planned to take place immediately after the initial coin offering.
- The potential concept
Digipharm aims at the more efficient, quicker and cheaper services for healthcare for everyone. In addition, monetization of patient data is enabled by allowing users to be in control of their healthcare data. The data can be contributed to health-related research and allow for patients to earn money. Health is one of the things that people have a concern about the most. Therefore, the concept of better and cheaper health services are soon positively accepted by everyone.
The well-built whitepaper
The well-built whitepaper
The 52-page whitepaper of Digipharm is available at: https://digipharm.ch/docs/DigipharmWP.pdf.
It contains the information about the problems and solutions offered by the team of Digipharm. In addition, there are paragraphs dedicated to the team’s profiles and their analysis on the market and the details of token sales. This white paper is very nicely-designed and the information is illustrated in details. Excellent!
- The well-designed website
Besides the good whitepaper, the website is also very detailed, contains all necessary graphics and information about the solution and the team. You will also be given the links to social media pages and documents. You can now join their token sale by visiting their website. The information is listed right at the home page.
Token sale
DPH is the only official token of the project and will be the currency for all transactions made within the community. The total number of released token is 100 million and no more tokens will be issued, the unused DPHs will be burnt.
65% of the entire token will be offered to the public during the token. The token sale will be in two stages; the pre-ICO and the ICO at the price 1 DPH = 1 USD. More details about all discount on different stages catch in their whitepaper.
Conclusion
To sum it up, аs а pаrt of our review, we see strong potentiаl in this ICO. The concept of the project is very useful and potentiаlly very profitаble. The site’s design looks good and all of the information are provided transparently and with many details. Going by their strong team and extensive roadmap on the website, DIGIPHARM definitely does not seem like a short term project, it is worth investing both from short аnd long-term perspectives
The sooner you will support the project by buying its tokens, the better price you mаy expect аlong with bonuses. So far, the platform looks promising with all the required areas covered. However, we advise you to invest carefully as there is no 100% guarantee on success. Also, the security market may sound a bit risky for some new investors.
Please: If you found this article helpful, appreciate the information I have curated, appreciate the analysis I have provided, please support me by liking and sharing this article; you can also follow me at ICO Review to stay updated with the most remarkable ICOs coming up. If you find the project valuable or interesting, support it by sharing and liking this page and keeping up with company profiles.
0 coment: